论文部分内容阅读
用红霉素及重组α2-干扰素与复合免疫球蛋白制剂(CTP)联合用药治疗孕妇衣原体病,对其疗效进行了对比研究。31例病人(第一组)口服红霉素,每天两次,每次500mg,为时14～15天。另外30例孕妇用阴道栓剂,(300mgCTP,2.0x10°IU的重组α2-干扰素)和15(2)～30ml阴道用溶液(含类似剂量CTP与重组α2-干扰素)。治疗后立即发现了第一组有7例和第二组有3例有衣原体临床症状。实验室证实,治疗后第一组发生
Erythromycin and recombinant α2-interferon and compound immunoglobulin preparation (CTP) combination therapy for the treatment of chlamydia in pregnant women, the efficacy of a comparative study. Erythromycin was given orally to 31 patients (group 1) twice daily for 500 mg for 14 to 15 days. Another 30 pregnant women were given vaginal suppositories (300 mg CTP, 2.0 × 10 ° IU recombinant α2-interferon) and 15 (2) to 30 ml vaginal solutions (with similar doses of CTP and recombinant α2-interferon). Immediately after treatment, seven patients in the first group and three patients in the second group had clinical symptoms of chlamydia. The laboratory confirmed that the first group occurred after treatment